New York, NY (December 8, 2004) Findings from one of the nation's largest and most comprehensive surveys about children and asthma to date, Children and Asthma in America, reveal that more than half (54%) of all children with asthma had a severe asthma attack in the past year and more than one quarter (27%) had an asthma attack so bad they thought their life was in danger. The survey results released today underscore the severity of asthma in children in the U.S. and the significant impact the disease has on children and their families.
Presented on behalf of Asthma Action America, the survey findings suggest the U.S. is still falling far short of the national treatment goals established for asthma, and reveal the majority of children with asthma do not have it under control. This places children at potential risk for a variety of consequences including frequent symptoms, missed school, restrictions on activities, emotional distress, hospitalization and even life-threatening asthma attacks. Asthma is one of the most common chronic illnesses among children, with an estimated 5.8 million American children four to 18 years of age currently with the condition.
"These are disturbing findings, especially since asthma is a highly controllable disease," said William Sears M.D, nationally acclaimed author, pediatrician and associate clinical professor of pediatrics at the University of California Irvine School of Medicine. "We need to help parents recognize that proper asthma control means children are symptom-free all or most of the time. Parents should talk to their healthcare professional about prevention of asthma symptoms and long-term management so their child does not suffer needlessly."
Asthma Control in Children: Are We Missing The Mark?
In the survey, four out of five respondents reported that their or their child's asthma was well (43%) or completely controlled (35%), yet children missed the mark on nearly evPage: 1 2 3 4 5 Related medicine news :1
Contact: Kathryn Ritzinger
Cohn & Wolfe
. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR2
. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease3
. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes4
. Landmark study demonstrates potential for nerve regeneration treatment of stroke5
. Landmark study results published in NEJM highlight breakthrough treatment for heart failure6
. Landmark study uncovers reasons behind recurring back injury7
. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients8
. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis9
. Landmark school-based social influences smoking-prevention program found not to work10
. U.S., British scientific societies honor penicillin as International Chemical Landmark11
. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe